May 12, 2022
Targovax ASA: First quarter 2022 results
Media
May 11, 2022
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 11, 2022
Aro Biotherapeutics to Present New Preclinical Data Highlighting the Potential of Centyrin-siRNA Conjugates for the Treatment of Pompe Disease
May 11, 2022
Targovax announces clinical collaboration with Agenus for upcoming ONCOS-102 phase 2 melanoma trial
May 11, 2022
Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events
May 11, 2022
Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)
May 11, 2022
Targovax to present at upcoming conferences
May 10, 2022
Fusion Pharmaceuticals Announces First Quarter 2022 Financial Results And Clinical Program Updates
May 10, 2022
Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma
May 06, 2022
Nordic Nanovector ASA: Invitation to First Quarter 2022 Results Presentation and Webcast